Polyrizon Ltd.
PLRZ- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001893645
No open-market purchases or sales by Polyrizon Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $2.77M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Polyrizon Ltd. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 3 | 4 | +1 |
| Shares | 15.1K | 35.9K | +20.8K (+138.1%) |
| Value | $127.9K | $413.6K | +$285.6K (+223.2%) |
New holders (3)
Institutions that held Polyrizon Ltd. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 24,575 | $283.0K | 0.13% |
| Citadel Advisors LLC | 10,149 | $117.1K | 0.00% |
| Legacy Wealth Managment, LLC | 1,150 | $13.4K | 0.01% |
Sold out (2)
Institutions that held Polyrizon Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 14,032 | $119.1K |
| UBS Group AG | 1,025 | $8.70K |